Aralez Pharmaceuticals Canada

Aralez Pharmaceuticals Canada was a specialty pharmaceutical company focused on the commercialization of products in cardiovascular health, pain management, and allergy. The company was established following the merger of POZEN and Tribute Pharmaceuticals and maintained a significant presence in the Canadian market with a portfolio of branded medications. In 2018, the company initiated restructuring proceedings under the CCAA, leading to the acquisition of its Canadian operations by Nuvo Pharmaceuticals (later renamed Miravo Healthcare) in early 2019. Its legacy portfolio includes well-known brands such as Vimovo, Cambia, and Blexten. The assets are currently managed under the Searchlight Pharma umbrella following subsequent acquisitions.